• Home
  • Search
  • Hofbauer Cell Reduction in GDM: Does a Decreased Quantity Mask a Deeper Immunovascular Dysfunction?
  • https://doi.org/10.1111/aji.70232Copy DOI Icon

Hofbauer Cell Reduction in GDM: Does a Decreased Quantity Mask a Deeper Immunovascular Dysfunction?

  • Abstract
  • Literature Map
  • References
  • Similar Papers
Abstract

Dear Editor, We carefully reviewed the article by Fakonti et al. regarding changes in the number and phenotype of Hofbauer cells (HBCs) in placentas from pregnancies with gestational diabetes mellitus (GDM) [1]. This study demonstrated that GDM is associated with a decrease in HBC abundance in terminal villi without changes in the M2-like phenotype, and a positive correlation between HBC markers and PECAM1/CD31. These findings are important because they reinforce the concept that fetal macrophages play a role in placental vascular homeostasis. However, the quantitative reduction in HBCs likely represents only part of a more complex spectrum of immunovascular dysfunction in GDM. First, the absence of an M1/M2 phenotype shift at the classical marker level does not necessarily rule out functional reprogramming. Recent research suggests that the M1/M2 dichotomy is insufficient to characterise differences among placental macrophages [2]. Single-cell studies of first-trimester HBCs have shown that subpopulations exist with distinct transcriptomic profiles associated with angiogenesis and immune control [3]. Consequently, GDM may not induce classical M1 polarisation. However, using a limited panel of markers, it may modulate specific HBC subtypes that would otherwise be undetectable. Hidden alterations in metabolic pathways, oxidative responses, or phagocytic capacity may be uncovered through high-resolution transcriptomic analysis or functional proteomic approaches. Second, the hypothesis of a pro-angiogenic role of HBC, previously mentioned [4], is supported by the positive correlation between HBC markers and PECAM1/CD31 in this study [1]. However, this correlation is associative and occurs in an immature placenta. Given that villus angiogenesis is most active in the first and middle trimesters, GDM, which is often diagnosed at 24–28 weeks, may disrupt HBC dynamics early, before it becomes clinically apparent. According to the Developmental Origins of Health and Disease (DOHaD) model, intrauterine exposure to hyperglycaemia can program the fetal immune response in the long term [5, 6]. Therefore, the decrease in HBC at term may be a cumulative result of early insults that cannot be accurately traced to the end of gestation. Third, further research is needed to examine the immunological impact of HBC reduction on the risk of neonatal infection. HBC can actively ward off viral and bacterial antigens [7, 8]. Hyperglycaemia is well known to impair innate immune function and macrophage phagocytosis [9]. In the case of GDM, experimental studies assessing the HBC response to TLR stimulation or ex vivo infection would be invaluable. This is because infants born to diabetic mothers are more susceptible to infection. This is because the combination of HBC reduction and possible metabolic dysfunction can contribute to immunological vulnerability in the fetoplacental unit. Fourth, the lack of association between HBC changes and LGA status in this study [1] raises an important question: do HBCs play a role in the quality of vascularisation rather than the quantity of fetal growth? Systematic pathology studies have shown that GDM is associated with changes in vascular architecture and villous maturity [10]. The possibility that HBCs modulate nutrient exchange efficiency through interactions with endothelial cells or the extracellular matrix, without directly determining birth weight, needs to be tested using functional approaches, such as HBC–endothelial co-cultures or placental organoid models. Furthermore, we appreciate the authors' methodological approach, which focused on terminal villi analysis and area normalisation to reduce sampling bias. However, to clarify the relationship between hyperglycaemia and HBC dynamics, we could have incorporated clinical data on glycaemic control, insulin therapy, or continuous glucose monitoring, which are known to be associated with fetal outcomes [6]. Overall, the study by Fakonti et al. [1] shows that GDM is associated with decreased HBC counts, without changes in the classical M2 phenotype. Moving from quantitative to functional and temporal descriptions of HBC in GDM is the next step in the scientific discussion. Whether HBC reduction is an epiphenomenon or a primary mediator of placental immunovascular dysfunction in gestational diabetes can be answered by multi-omics approaches, longitudinal analyses across trimesters, and in vitro mechanistic studies. This approach is not only relevant to reproductive immunology but also has the potential to bridge understanding of the links between placental inflammation, angiogenesis, and cardio metabolic disease programming in offspring. The authors have nothing to report.

Similar Papers
  • PDF
  • Research Article
  • Citations23

Hofbauer cells morphology and density in placentas from normal and pathological gestations

  • Sep 01, 2013
  • Revista Brasileira de Ginecologia e Obstetrícia
  • Charalampos Grigoriadis +6
  • Abstract
  • Citations1

4 Placental Hofbauer Cells As a Proxy Cell Type for Fetal Brain Microglia

  • Feb 01, 2021
  • American Journal of Obstetrics and Gynecology
  • Rose De Guzman +6
  • Research Article

Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto-Maternal Outcomes in Women With Gestational Diabetes and Pre-Gestational Diabetes: A Systematic Review and Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.

  • Apr 07, 2026
  • Diabetes, obesity & metabolism
  • Deep Dutta +5
  • Research Article
  • Citations5

Placenta analysis of Hofbauer cell profile according to the class of antiretroviral therapy used during pregnancy in people living with HIV

  • Jun 12, 2023
  • Placenta
  • Stephanie Hindle +9
  • Book Chapter
  • Citations8

Chapter 15 - Hofbauer cells and placental viral infection

  • Jan 01, 2021
  • Reproductive Immunology
  • Victoria Chase +1
  • Research Article
  • Citations2

NICE's latest guidelines on diabetes in pregnancy: getting the balance right

  • Apr 01, 2015
  • Practical Diabetes
  • Helen Holt
  • Research Article

A randomized controlled trial to evaluate the efficacy of continuous glucose monitoring system for perinatal outcome and glycemic control in women with gestational diabetes mellitus and pregnant women with type 2 diabetes

  • Oct 09, 2025
  • Medicine: Case Reports and Study Protocols
  • Moeko Kubo +17
  • Research Article

Baby’s First Macrophage: characterizing Hofbauer Cell phenotype through gestation using unsupervised dimensionality reduction

  • May 01, 2020
  • The Journal of Immunology
  • Dominika Swieboda +4
  • Research Article
  • Citations15

Herpesvirus-infected Hofbauer cells activate endothelial cells through an IL-1β-dependent mechanism

  • Jan 25, 2020
  • Placenta
  • Paul Hendrix +6
  • Research Article
  • Citations95

Diabetes during pregnancy influences Hofbauer cells, a subtype of placental macrophages, to acquire a pro-inflammatory phenotype

  • Jul 19, 2013
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  • Giorgia Sisino +5
  • PDF
  • Research Article
  • Citations56

Obesity and gestational diabetes independently and collectively induce specific effects on placental structure, inflammation and endocrine function in a cohort of South African women.

  • Feb 27, 2023
  • The Journal of Physiology
  • Ezekiel Musa +5
  • Research Article
  • Citations4

The Cost of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes Pregnancies in the United States: A Cost-Consequences Analysis Using Real-World Evidence.

  • Apr 01, 2025
  • Diabetes technology & therapeutics
  • Michael J Distefano +5
  • Supplementary Content
  • Citations119

The Elusive Role of Placental Macrophages: The Hofbauer Cell

  • Jan 01, 2019
  • Journal of Innate Immunity
  • Michael Z Zulu +3
  • Research Article

Clinical characteristics of ketosis in patients with gestational diabetes mellitus

  • Aug 27, 2017
  • Chin J Diabetes Mellitus
  • Rui Wang +1
  • Research Article

Value appraisal of the application of continuous glucose monitoring system in patients with advanced gestational diabetes mellitus

  • Jun 11, 2008
  • The Journal of practical nursing
  • 谢翠华 +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.